Product Information
- Methyl 3-(phenylmethoxy)benzeneacetate
- 3-Benzyloxyphenylacetic acid methyl ester
- Methyl [3-(benzyloxy)phenyl]acetate
- Benzeneacetic acid, 3-(phenylmethoxy)-, methyl ester
Methyl 2-[3-(benzyloxy)phenyl]acetate (MBPCA) is a patent-pending lead compound with potential pharmacological applications as an inhibitor of acetyl-coa carboxylase. MBPCA has been shown to reduce plasma triglyceride levels in subchronic studies and is being developed as a potential treatment for hypertriglyceridemia. MBPCA has been shown to be effective against high fat diet-induced obesity, increasing the level of fat oxidation and reducing body weight gain. The pharmacokinetic properties of MBPCA are currently being optimized, including parameters such as bioavailability, volume of distribution, and clearance.
Chemical properties
Technical inquiry about: 3D-MCA96942 Methyl 2-[3-(benzyloxy)phenyl]acetate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.